Literature DB >> 11411913

Dermatoscopic prediction of melanoma thickness using latent trait analysis and likelihood ratios.

H F Lorentzen1, K Weismann, F G Larsen.   

Abstract

Breslow thickness and Clark level can be used to determine surgical procedures for cutaneous malignant melanoma and patient eligibility for experimental adjuvant therapy. Efforts to predict the thickness of melanomas using dermatoscopy have focused on differences between single dermatoscopic findings. The aim of this study was to develop a method for preoperative identification of melanomas of > or = 1 mm Breslow thickness using the entire range of dermatoscopic findings. Sixty-five melanomas were assessed for the presence of 22 dermatoscopic features. Ten dermatoscopic features showed differences in thick and thin melanomas and were selected for further analysis. A latent trait analysis construct implied that a progression in dermatoscopic features was associated with advancement of melanomas. Early melanomas are characterized by a light brown colour, a pigment network and irregularity or heterogeneity. Gray-blue areas, white scar-like areas and an atypical vascular pattern gradually displace these features. Likelihood ratios were determined for these 6 dermatoscopic findings and an algorithm for calculating the probability of thick malignant melanoma was established.

Entities:  

Mesh:

Year:  2001        PMID: 11411913     DOI: 10.1080/000155501750208173

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Dermoscopic and clinical features of trunk melanomas.

Authors:  Nazan Emiroglu; Fatma Pelin Cengiz; Rainer Hofmann-Wellenhof
Journal:  Postepy Dermatol Alergol       Date:  2014-12-03       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.